Related Experiment Videos
[Perennial coseasonal hyposensitisation (author's transl)]
Wiener Medizinische Wochenschrift (1946)
|April 30, 1980
Summary
Perennial-coseasonal hyposensitisation offers significant advantages over preseasonal treatment for pollinosis (hay fever). This causal therapy effectively reduces hay fever symptoms, with many patients achieving complete relief.
Area of Science:
- Allergy and Immunology
- Immunotherapy
- Respiratory Medicine
Context:
- Pollinosis, commonly known as hay fever, affects a significant portion of the population.
- Traditional treatments often focus on symptom management rather than addressing the underlying cause.
- The need for effective, causal therapies for allergic rhinitis is well-established.
Purpose:
- To describe a specific method of perennial-coseasonal hyposensitisation for pollinosis.
- To evaluate the efficacy and safety of this low-dosage, individualized coseasonal treatment approach.
- To compare the outcomes of coseasonal treatment with traditional preseasonal methods.
Summary:
- A novel hyposensitisation technique using low-dose, individualized coseasonal antigen administration for pollinosis is detailed.
- The study documented the antigen application technique, potential side effects, and their management.
- Results from 50 pollinosis patients showed 40 achieved symptom freedom within one year of coseasonal therapy.
Impact:
- Demonstrates the effectiveness of perennial-coseasonal hyposensitisation in achieving symptom relief for pollinosis patients.
- Highlights the potential for reduced reliance on adjuvant therapies like antihistamines.
- Provides a viable alternative causal treatment for allergic rhinitis, improving patient quality of life.